Alliance for Prostate Cancer Prevention (APCaP) has been
created to support efforts to prevent the serious consequences of the
disease itself for men who have not been diagnosed and are unaware of
the deadly effects of prostate cancer.
APCaP includes the following members (click each
name to view their photo and bio):
The goal of
this diversified stakeholder group is to implement and evaluate
ambitious plans that are designed to eliminate prostate cancer as a
health threat in the United States by 2010.
|
|
|
Scientific Advisory Board
William J. Catalona, M.D.
Robert H. Lurie
Comprehensive Cancer Center of NorthWestern University, Chicago
E. David Crawford, M.D.
Univ. of Colorado, H.S.C
Robert C. Flanigan, M.D.
Loyola Univ., M.C
Philip Kantoff, M.D.
Dana Farber C. Institute
Eric Klein, M.D.
Cleveland Clinic
Paul Lange, M.D.
Univ. of Washington
Herbert Lepor, M.D.
NYU, M.C
Judd W. Moul, M.D.
Prof. & Chair, Dept.
of Urology
Duke University
Medical School
Mark Moyad, M.S.
Univ. of Michigan
Alan W. Partin, M.D.
James Brady Uro. Institute
Arthur T. Porter, M.D.
The Detroit M.C.
Peter T. Scardino, M.D.
MSKCC
Paul Schellhammer, M.D.
E. Virginia Med. School
Eric Small, M.D.
Univ. California at S.F.
Ian M. Thompson, M.D.
Univ. of Texas M.C.
Nick Vogelsang, M.D.
Univ. of Chicago C.C.
George Wilding, M.D.
Univ. of Wisconsin C.C. |
